Get the content you want anytime you want.
REGISTER NOW | SIGN IN
VIDEO

Long-Acting Injectable: An Exciting New Option for HIV Prevention

SEP 30, 2017 | CONTAGION® EDITORIAL STAFF


Alex Rinehart, PhD, Director, Global Prevention Strategy, ViiV Healthcare, explains how the development of a long-acting injectable could potentially offer a new preventive option for individuals at risk for HIV.
To stay informed on the latest in infectious disease news and developments, please sign up for our weekly newsletter.


FEATURED
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.